Joyce Karoline da Silva

Joyce Karoline da Silva

Auto-generated profile, based on publicly available information

Joyce Karoline da Silva

Instituto Gonçalo Moniz

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2026 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
AHAdolfo Alexis Rojas Hidalgo
Adolfo Alexis Rojas Hidalgo
RARaúl Arias-Carrasco
Raúl Arias-Carrasco
JSJoyce Karoline Silva
Joyce Karoline Silva
EAErick Armingol
Erick Armingol
SUSebastián Urquiza-Zurich
Sebastián Urquiza-Zurich
VMVinicius Maracaja-Coutinho
Vinicius Maracaja-Coutinho

21 July 2026 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
TCThiago Cerqueira-Silva Cerqueira-Silva
Thiago Cerqueira-Silva Cerqueira-Silva
Laise de MoraesLaise de Moraes
Laise de Moraes
BPBlenda de Jesus Pereira
Blenda de Jesus Pereira
JSJessica de Jesus da Silva
Jessica de Jesus da Silva
COCibele Orge
Cibele Orge
VBViviane Sampaio Boaventura
Viviane Sampaio Boaventura
Background: Postacute viral syndromes are increasingly recognized as causes of prolonged disability, with a notably higher prevalence in women. This study investigated the immune signature of individuals who progressed to chronic chikungunya (CC), a condition characterized by persistent arthralgia and examined the role of biological sex in disease outcomes. Methods: We analyzed peripheral blood mononuclear cells from patients, recruited between 2016 and 2020, sampled within 7 days of disease onset. The study compared patients who eventually recovered (RC, n = 11) with those who progressed to CC (n = 24), alongside 9 healthy controls. We identified differentially expressed genes using bulk RNA-seq and validated key findings by qRT-PCR and flow cytometry. Results: Ten genes were differentially expressed between CC and RC. Specifically, IKZF2 was upregulated in CC patients, which was validated by qRT-PCR. Conversely, ACKR3 was upregulated in RC patients, a finding validated by flow cytometry. Furthermore, CC cases demonstrated higher viral loads and downregulation of IFN-α and IFN-γ pathways compared to RC. We also found that immune profiles differed between men and women; specifically, IFNα and IFN-γ and TNF-signaling pathways were upregulated in women with CC but downregulated in men with CC relative to recovered individuals. Conclusion: Our findings suggest that progression to CC is influenced by an impaired early antiviral response combined with sex-specific immune regulation. Furthermore, ACKR3 and IKZF2 were identified as potential prognostic biomarkers for CC. These biomarkers may enable early identification of patients at risk of chronic disease, informing timely intervention strategies.